Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034800 · ClinicalTrials.gov registry record
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
NCT01034800: Completed study, sponsored by National Institute on Drug Abuse (NIDA).
NCT01034800 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034800 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
Study Summary
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-09 |
What the finished NCT01034800 record still lists
NCT01034800 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT01034800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01034800 about?
NCT01034800 is a clinical study titled "The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215". The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose ...
What is the current status of trial NCT01034800?
This trial is currently completed. The study started on 2006-09.
Who is sponsoring clinical trial NCT01034800?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia